Severe Cerebral Small Vessel Disease Is Associated With Excess Long-Term Mortality Risk, but Can We Define "Severe cSVD"?

Neurology

From the Centre for Clinical Brain Sciences (S.M.M., C.A.-R.); and UK Dementia Research Institute (S.M.M., C.A.-R.), University of Edinburgh, Edinburgh, United Kingdom.

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000209762DOI Listing

Publication Analysis

Top Keywords

severe cerebral
4
cerebral small
4
small vessel
4
vessel disease
4
disease associated
4
associated excess
4
excess long-term
4
long-term mortality
4
mortality risk
4
risk define
4

Similar Publications

Tuberculous meningitis diagnosis and treatment: classic approaches and high-throughput pathways.

Front Immunol

January 2025

Rehabilitation Medicine Department, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University (The First Hospital of Changsha, Changsha, China.

Tuberculous meningitis (TBM), a severe form of non-purulent meningitis caused by (Mtb), is the most critical extrapulmonary tuberculosis (TB) manifestation, with a 30-40% mortality rate despite available treatment. The absence of distinctive clinical symptoms and effective diagnostic tools complicates early detection. Recent advancements in nucleic acid detection, genomics, metabolomics, and proteomics have led to novel diagnostic approaches, improving sensitivity and specificity.

View Article and Find Full Text PDF

Background: A considerable proportion (21%) of patients with common variable immunodeficiency (CVID) suffers from depression. These subjects are characterized by reduced naïve T cells and a premature T cell senescence similar to that of patients with major depressive disorder (MDD). It is known that T cells are essential for limbic system development/function.

View Article and Find Full Text PDF

Background And Objective: Lyme disease, caused by , presents major health challenges worldwide, leading to serious neurological and musculoskeletal issues that impact patients' lives and healthcare systems. This systematic review and meta-analysis aim to determine the prevalence and link between Lyme disease and these complications, aiming to enhance clinical and public health approaches.

Methods: We systematically searched PubMed, EMBASE, and Web of Science up until April 01, 2024, to find studies reporting the prevalence and severity of neurological and musculoskeletal complications associated with Lyme disease.

View Article and Find Full Text PDF

Mechanisms of Cancer-Induced Bone Pain.

J Pain Res

January 2025

Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.

Bone is a common site of advanced cancer metastasis, second only to the lungs and liver. Cancer-induced bone pain (CIBP) is a persistent and intense pain that is caused by a combination of inflammatory and neuropathic factors. As CIBP progresses, the degree of pain intensifies.

View Article and Find Full Text PDF

Co-existing neuropathological comorbidities have been repeatedly reported to be extremely common in subjects dying with dementia due to Alzheimer disease. As these are likely to be additive to cognitive impairment, and may not be affected by molecularly-specific AD therapeutics, they may cause significant inter-individual response heterogeneity amongst subjects in AD clinical trials. Furthermore, while originally noted for the oldest old, recent reports have now documented high neuropathological comorbidity prevalences in younger old AD subjects, who are more likely to be included in clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!